3.15.2025

Still on track

Due to the enormous workload over the past ten days, it took me significantly longer to finalize the results for February's dividends. The marginal strengthening of the Swedish krona against other currencies, including the US dollar, at the end of February was within the tolerance for my forecast to be correct.

As the Swedish krona has strengthened further this month against the US dollar, there is an imminent risk that we will not meet the forecast for March.

Click to enlarge


Click to enlarge

No comments:

Post a Comment

Can go either way

Yesterday I bought a small number of shares of Pfizer, Inc. Common Stock (PFE) . The reason we continue to trade shares in (PFE) is that we ...